Fenoprofen in the treatment of osteoarthrosis of hips and knee joints in the elderly.

Abstract

Twenty-one patients between the ages of 68 and 89 years with osteoarthrosis of hips and/or knee joints wre studied. One group was treated with fenoprofen 300 mg t.d.s. for 5 days, and the other group with 600 mg t.d.s. for 5 days. No therapeutic advantage was found with the higher dose, and the side-effects were minimal on either dosage. Treatment of elderly patients with the smaller dose is recommended.

• Authors: N K Chakravorty, G Annan
• Journal: The Journal of international medical research (J Int Med Res) Vol. 8 Issue 4 Pg. 270-5 ( 1980) ISSN: 0300-0605 [Print] England
• PMID: 7409301 (Publication Type: Journal Article)

Chemical References

• Phenylpropionates
• Fenoprofen

Topics

• Aged
• Bone Diseases (drug therapy)
• Female
• Fenoprofen (administration & dosage, blood, therapeutic use)
• Hip Joint
• Humans
• Joint Diseases (drug therapy)
• Knee Joint
• Male
• Phenylpropionates (therapeutic use)